Tool

Compare any two NAD⁺ sellers

We publish 154 NAD⁺ sellers, which makes 11,781 possible head-to-heads. Writing that many pages would produce 11,781 thin ones, so this does it here instead. Pick two.

Disclosure: NAD Picks is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. Partners are listed first; a commission never changes what we write about a provider. How we make money.

First seller

Second seller

On the injection both sell: AgelessRx $149mo against AquaVita NextGen $599vial.

AgelessRx is 302% less — about $5400 over twelve months, if neither price moves.

What they tell you	AgelessRx	AquaVita NextGen
Publishes a dose	✓	—
Names its pharmacy	—	—
States LegitScript	✓	—
Advertised price catch	Quarter paid up front	—
FDA warning letter	—	—
Formats sold	injection, nasal spray, patch	injection

Read the AgelessRx review →Read the AquaVita NextGen review →

How the price line works

It compares a format both sellers actually sell. That sounds obvious and is the thing most comparisons get wrong: a seller’s headline figure is whichever product it leads with, so putting one company’s nasal spray next to another’s injection produces a difference that is about two different products rather than about price.

Where two sellers share no format with a published price, it says so rather than inventing a comparison. That happens more often than you would expect, because a third of sellers publish no price at all until you start an intake.

What the table cannot do

It compares what two companies disclose and charge. It does not compare whether the treatment works, because on that question they are the same: no controlled outcome trial supports injected NAD⁺ for the things it is sold for, whichever company you pick.

A cheaper price with no published dose is also not necessarily cheaper. If you can get milligrams for both, cost per milligram is the comparison that survives — and the scorecard shows how few sellers make it possible.